Former OtisMed CEO Sentenced for Selling Unapproved Surgical Devices
The former president and CEO of OtisMed Corporation was sentenced today to serve two years in prison for intentionally distributing a medical device used in knee replacement surgery after its application for marketing clearance had been rejected by the Food and Drug Administration (FDA), the Department of Justice announced.
Action Details
- Date:June 26, 2015
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions